Sprint Bioscience Competitors and Similar CompaniesClear all
Sprint Bioscience's competitors and similar companies include Epizyme.
 Sprint Bioscience Sprint Bioscience is a pharmaceutical company focused on developing drugs to fight cancer. |  Epizyme Epizyme is a clinical stage biopharmaceutical company focusing on treatments for blood cancer and tumors. | |
Founding Date | Founding Date 2009 | Founding Date 2007 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Huddinge, SE HQ | Locations Cambridge, US HQ |
Employees | Employees 38 | Employees 20364% increase |
Valuation ($) | Valuation ($) 13.8 m | Valuation ($) 250.8 m |
Financial | ||
Revenue (est.) | Revenue (est.) kr167.2m (FY, 2025) | Revenue (est.) $37.4m (FY, 2021) |
Cost of goods | Cost of goods kr13.1m (FY, 2025) | Cost of goods $10.5m (FY, 2021) |
Net income | Net income kr91.7m (FY, 2025) | Net income ($251.1m) (FY, 2021) |
Funding | ||
Total funding raised | Total funding raised $ 5.4m | Total funding raised $ 51.5m |
For sources of this data, please see the company profile
View Company Profiles
Epizyme
HQ
Cambridge, US
Employees
203
Epizyme is a clinical stage biopharmaceutical company focusing on treatments for blood cancer and tumors.
View company